Literature DB >> 2092099

Beta-endorphin concentrations both in plasma and in cerebrospinal fluid in response to acute painful stimuli.

R Spaziante1, B Merola, A Colao, G Gargiulo, T Cafiero, C Irace, E Rossi, C Oliver, G Lombardi, B Mazzarella.   

Abstract

The beta-endorphin-like-immunoreactivity (beta-ELI) has been evaluated both in plasma and in cerebrospinal fluid (CSF) in 30 patients during trans-sphenoidal surgery. Blood and liquoral samples were collected in five conditions: (1) "reference", (2) "pain", (3) "analgesia", (4) "end", and (5) "24th hour". A significant rise of both plasma and liquoral beta-ELI levels (p less than 0.00001 and p less than 0.08, respectively) when compared to basal ones occurred following the painful stimulation due to the divarication of the nasal mucosa by speculum. A significant decrease (p less than 0.01) was noticed for plasma concentrations at the third sample followed by a new significant increase at the end of the operation, (p less than 0.05 when compared to the third sample and p less than 0.01 when compared to the reference sample). In CSF, beta-ELI levels decreased at the third sample (p less than 0.01 when compared to the painful levels) and at the end of surgery (p less than 0.01, p less than 0.01 and p less than 0.05 vs first, second and third samples, respectively). Twenty-four hours after surgery either plasma and liquoral beta-ELI levels decreased (p less than 0.05). The modifications of the opiatergic system after acute painful stimuli should be, hence, characterized by an early rise followed by a progressive decrease of beta-ELI concentrations. The increase of plasma beta-ELI levels, at the end of surgery, could be due to pituitary manipulation with massive release in the peripheral blood.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2092099

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  8 in total

Review 1.  Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.

Authors:  Fernando Berrendero; Patricia Robledo; José Manuel Trigo; Elena Martín-García; Rafael Maldonado
Journal:  Neurosci Biobehav Rev       Date:  2010-02-16       Impact factor: 8.989

2.  Flurbiprofen axetil enhances analgesic effect of fentanyl associated with increase in β-endorphin levels.

Authors:  Zhao-Fang Liu; Xiao-Qing Chai; Kun-Zhou Chen
Journal:  J Anesth       Date:  2011-07-02       Impact factor: 2.078

3.  Adrenocorticotropic hormone and beta-endorphin concentrations in the inferior petrosal sinuses in Cushing's disease and other pituitary diseases.

Authors:  A Colao; B Merola; R Spaziante; G La Tessa; F Boudouresque; C Oliver; G Lombardi
Journal:  J Endocrinol Invest       Date:  1992-12       Impact factor: 4.256

4.  What do plasma beta-endorphin levels reveal about endogenous opioid analgesic function?

Authors:  S Bruehl; J W Burns; O Y Chung; M Chont
Journal:  Eur J Pain       Date:  2011-12-19       Impact factor: 3.931

Review 5.  The effects of beta-endorphin: state change modification.

Authors:  Jan G Veening; Henk P Barendregt
Journal:  Fluids Barriers CNS       Date:  2015-01-29

6.  Expression of TRPM8 in the distal cerebrospinal fluid-contacting neurons in the brain mesencephalon of rats.

Authors:  Jing Du; Xinwei Yang; Licai Zhang; Yin-Ming Zeng
Journal:  Cerebrospinal Fluid Res       Date:  2009-03-17

7.  Volume transmission of beta-endorphin via the cerebrospinal fluid; a review.

Authors:  Jan G Veening; Peter O Gerrits; Henk P Barendregt
Journal:  Fluids Barriers CNS       Date:  2012-08-10

Review 8.  Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.

Authors:  Ewa Gibula-Tarlowska; Jolanta H Kotlinska
Journal:  Biomolecules       Date:  2020-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.